Method for percutaneously administering metoclopramide

Details Method for percutaneously administering metoclopramide Method for percutaneously administering metoclopramide

A - Human Necessities

61

K

167/268

A61K 31/165 (2006.01) A61K 9/70 (2006.01) A61K 47/00 (2006.01) A61K 47/10 (2006.01) A61K 47/14 (2006.01) A61K 47/22 (2006.01)

Patent

CA 1252049

ABSTRACT OF THE DISCLOSURE A method of percutaneously administering meto- clopramide which comprises applying to the skin of a mammal metoclopramide in a carrier system which comprises at least one adjuvant and at least one solvent. The adjuvant is a monovalent alcohol ester of an aliphatic monocarboxylic acid or an aliphatic monoalcohol. The solvent is a pyrrolidone-type compound. Mixtures can also be used.

468965

Affiliated with

Also associated with

Rating

Method for percutaneously administering metoclopramide does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method for percutaneously administering metoclopramide, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for percutaneously administering metoclopramide will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1266360